Scientific and Research Committees

When evaluating proposals for research funding and following up on funded project results, the IWMF relies on the assistance of several committees. The Scientific Advisory Committee (SAC) is comprised of top WM researchers from around the world, and its members provide guidance on the direction of the IWMF’s research strategy. Research grant proposals are solicited via the process of an annual Request for Proposals and evaluated by an independent committee composed of selected members of SAC and other experts as needed. The proposals are ranked according to National Institutes of Health (NIH) review criteria and forwarded to the IWMF Board of Trustees. Generally speaking, at this stage a decision to fund a proposal is based on proposal quality and fund availability. Once approved for funding, each project’s Principal Investigator submits periodic Progress Reports to the IWMF Research Committee, which is responsible for reviewing all Progress Reports and approving scheduled payments according to the terms of each project’s contract.

For a full list of the Scientific Advisory Committee (SAC) download the PDF here.

Scientific Advisory Committee (SAC)

Name	Medical Institution	Website
Stephen Ansell, MD, PhD (Co-Chair, IWMF SAC)	Mayo Clinic, Rochester, Minnesota	www.mayoclinic.org
Steven Treon, MD, PhD (Co-Chair, IWMF SAC)	Dana-Farber Cancer Institute, Boston, Massachusetts	www.dana-farber.org
James R. Berenson, MD	Institute for Myeloma & Bone Cancer Research, West Hollywood, California	www.imbcr.org
Christian Buske, MD	University Hospital, Ulm, Germany	uni-ulm.de
Jorge Castillo, MD	Dana-Farber Cancer Institute, Boston, Massachusetts	www.dana-farber.org
Morton Coleman, MD	Weill Cornell Medical College, New York, New York	www.nyp.org
Meletios Dimopoulos, MD	Alexandra Hospital, Athens, Greece	www.school.med.uoa.gr
Stanley Frankel, MD	Columbia University, New York, New York	www.cumc.columbia.edu
Morie Gertz, MD	Mayo Clinic, Rochester, Minnesota	www.mayoclinic.org
Irene Ghobrial, MD	Dana-Farber Cancer Institute, Boston, Massachusetts	www.dana-farber.org
Zachary Hunter, PhD	Dana-Farber Cancer Institute, Boston, Massachusetts	www.dana-farber.org
Prashant Kapoor, MD, FACP	Mayo Clinic, Rochester, MN	www.mayoclinic.org
Efstathios Kastritis, MD	National and Kapodistrian University of Athens, School of Medicine	en.uoa.gr
Eva Kimby, MD	Karolinska Institute, Stockholm, Sweden	ki.se/en/startpage
Monique Minnema, MD	UMC Utrecht, Netherlands	www.umcutrecht.nl/nl
Gwen L. Nichols, MD	The Leukemia & Lymphoma Society, Rye Brook, New York	www.lls.org
Roger Owen, MD	St. James’s Institute of Oncology, Leeds, United Kingdom	www.leedsth.nhs.uk
Lia Palomba, MD	Memorial Sloan Kettering Cancer Center	www.mskcc.org
Surinder Sahota, PhD	University of Southampton, United Kingdom	www.southampton.ac.uk
Sheeba Thomas, MD	MD Anderson Cancer Center, Houston, Texas	www.mdanderson.org
Marcel Spaargaren, Ph.D.	Amsterdam UMC	www.amsterdamumc.nl